Presentations -

天然物由来の新規コマロビキノン誘導体はP53欠損多発性骨髄腫を克服する

藤森宏太、岡山幹夫、市川大樹、松下 麻衣子、服部豊

[Domestic presentation]  第76回日本癌学会学術総会 (横浜市、神奈川県) , 

2017.09

, 

Oral presentation (general)

日本の抗がん剤の市場調査から示唆鎖される今後のがん治療の方向性

柴田翔洋、斎藤義正S、松下 麻衣子、鈴木岳之

[Domestic presentation]  第61回日本薬学会関東支部大会 (東京) , 

2017.09

, 

Poster presentation

本邦における抗悪性腫瘍の処方量の傾向分析

柴田翔洋、斎藤義正、松下 麻衣子、小板橋茜、鈴木岳之

[Domestic presentation]  第15回日本臨床腫瘍学会 (神戸市、兵庫県) , 

2017.07

, 

Poster presentation

PEG(E)-TC11は、CRBN非依存的に細胞周期の調節を介してハイリスク骨髄腫の増殖を抑制する

會田宗司、市川大樹、中村美沙、宇於崎涼、飯田和樹、穂積暢史、岡山幹夫、米村裕子、田畠典子、山田健人、松下 麻衣子、須貝威、柳川弘志、服部豊

[Domestic presentation]  第42回日本骨髄腫学会学術集会 (東京) , 

2017.05

, 

Poster presentation

Establishment of KU-MEL9-specific cytotoxic T cells for the development of adoptive immunotherapy for multiple myeloma.

Shinya Yokoe,Matsushita Maiko, Koji Ozawa, Akane Uchiumi, Syo Kashiwazaki, Daiju Ichikawa, Yutaka Hattori

[International presentation]  The 8th International Symposium 2017 in Miyazaki (Miyazaki, Japan) , 

2017.05

, 

Poster presentation

PEG(E)-TC11, a novel polyehylene glycol-linked phthalimide derivative, inhibited high-risk MM cell growth in vivo and in vitro via cell cycle G2/M arrest in a CRBN-independent manner.

Shuji Aida,Daiju Ichikawa, Kazuki Iida, Masashi Hozumi, Misa Nakamura, Ryo Uozaki, Nahoko Hashimoto, Mikio Okayama, Yuko Yonemura, Noriko Tabata, Taketo Yamada,Matsushita Maiko, Takeshi Sugai, Hiroshi Yanagawa, Yutaka Hattori

[International presentation]  2017 Annual meeting of American Association for Cancer Research (Washington D.C., U.S.A.) , 

2017.04

, 

Poster presentation

Komarovieuinone-derivatives, revealed anti-tumor effect on high-risk multiple myeloma cells in vitro as well as in vivo

Mariko Sato, Shotaro Kitabatake, Daiju Ichikawa, Yutaka Suto, Genji Iwasaki, FUmiyuki Kiuchi, Takashi Yamaguchi, Arimi Ueda,Shuji Aida,Matsushita Maiko,Yutaka Hattori

[International presentation]  58th American Society of Hematology Annual Meeting and Exposition (San Diego) , 

2016.12

, 

Poster presentation

Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma.

Sho Kashiwazaki, Satoshi Kamiko, Ryo Uozaki, Tomofumi Yamamoto, Daiju Ichikawa, Yutaka Hattori, Matsushita Maiko Matsushita, Maki Hirao, Hisako Kunieda and Kohei Yamazaki

[International presentation]  60th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (San Diego CA.) , 

2016.12

, 

Poster presentation

Structual optimization and anti-tumo activities of komaroviquinone to high-risk myeloma

Mariko Sato, Shotaro Kitabatake, Daiju Ichikawa, Yutaka Suto, Genji Iwasaki, FUmiyuki Kiuchi, Takashi Yamaguchi, Arimi Ueda,Shuji Aida,Matsushita Maiko,Yutaka Hattori

[Domestic presentation]  第78回日本血液学会学術集会 (横浜市) , 

2016.10

, 

Oral presentation (general)

本邦における造血器腫瘍薬市場の現状と今後の展望

柴田翔洋,和山祐亮,露木愛,松下 麻衣子,松木絵里,岡本真一郎,鈴木岳之

第14回日本臨床腫瘍学会学術集会 (神戸市) , 

2016.07

, 

Poster presentation

Immunogenicity of Novel Antigen Expressed in Leukemia Stem Cells.

Ozawa K, Matsushita M, Yokoe S, Kanchi S, Uchiumi A , Ichikawa D , Matsuki E , Sakurai M, Karigane D, Kasahara H , Kawakami Y , Okamoto S, Hattori Y.

[International presentation]  The 5thJCA-AACR Joint Conference, 

2016.07

, 

Poster presentation

ハイリスク多発性骨髄腫に対する新規komaroviquinone誘導体による克服薬の開発

佐藤真梨子,北畠翔太朗,藤森宏太,市川大樹,須藤豊,岩崎源司,木内文之,山口高史,植田有美,會田宗司,松下 麻衣子,服部豊

[Domestic presentation]  第41回日本骨髄腫学会学術集会 (徳島市) , 

2016.05

, 

Poster presentation

Identification of Novel HLA-A*24:02-Restricted Epitope Derived from PEPP2 Expressed in Hematological Malignancies.

Uchiumi A, Matsushita M, Otsuka Y, Tsutsumida N, Tanaka C, Ozawa K, Suzuki T, Ichikawa D,Okamoto S, Kawakami Y, Hattori Y.

[International presentation]  The 7th JSH International Symposium, 

2016.05

, 

Poster presentation

Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs.

Hozumi M, Ichikawa D, Matsushita Maiko, Kamiyama E, Yanagawa H, Tabata N, Kitabatake S, Ueda A, Yamaguchi T, Sato M, Hattori Y.

[International presentation]  57th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (Orlando, FL. U.S.A.) , 

2015.12

, 

Poster presentation

Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI.

Matsushita MaikoKoji Ozawa, Kanchi S, Uchiumi A, Suzuki T, Ichikawa D, Matsuski E, Sakurai M, Karigane D, Nakajima H, Okamoto S, Hattori Y.

[International presentation]  30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC） (National Harbor, MD, U.S.A.) , 

2015.11

, 

Poster presentation, The Society for Immunotherapy of Cancer（SITC）

Identification of New IMiDs-Binding Proteins and Nonteratogenic Drug Design for High-Risk Myeloma.

Hozumi M,Matsushita Maiko, Ichikawa D, Ozaki Y, Hasegawa Y, Terada F, Yanagawa H, Tabata N, Shiheido H, Oikawa T, Matsuo K, Yamada T, Wenlin Du W, Kitabatake S, Ueda A, Hattori Y

[Domestic presentation]  第77回日本血液学会 (石川県立音楽堂) , 

2015.10

, 

Oral presentation (general), 日本血液学会

イマチニブ投与中止後CML患者におけるがん幹細胞抗原特異的CTLの解析.

神地沙織,小澤光司,松下 麻衣子,松木絵里,櫻井政寿,雁金大樹,市川大樹,岡本真一郎,服部豊.

[Domestic presentation]  第７回血液疾患免疫療法研究会学術集会 (東京大学　伊藤謝恩ホール) , 

2015.09

, 

Oral presentation (general), 血液疾患免疫療法研究会

ハイリスク多発性骨髄腫に対する新規治療薬の開発

Matsushita Maiko

[Domestic presentation]  第16回 Pharmaco-Hematologyシンポジウム（日本薬学会生物系薬学部会）, 

2015.06

, 

Oral presentation (general)

白血病幹細胞に発現する新規がん精巣抗原の同定

Matsushita Maiko

[Domestic presentation]  第12回日本免疫治療学研究会学術集会, 

2015.02

, 

Poster presentation

Clinical and biological significance of codon 72 polymorphisms of TP53 gene in multiple myeloma.

Masashi Hozumi, Yurika Ikeda, Yuya Suzuki, Maiko Matsushita, Daiju Ichikawa, Arimi Ueda, Shotaro Kitabatake, Yutaka Hattori

[Domestic presentation]  The 76th Annual Meeting of the Japanese Society of Hematology, 

2014.10

, 

Oral presentation (keynote)